Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

April 23, 2007

intranasal antibiotics for chronic sinusitis

Analysis of: FDA Approves Fast Track Designation for Naryx Pharma’s Product for Chronic Sinusitis | www.naryxpharma.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Mitchell Boxer, MD
Assistant Clinical Professor, Albert Einstein College of Medicine
Implications: I have not found nebulized antibiotic therapy to be of great success in patients with chronic sinusitis.  There are already a few pharmacies that have formulated an array of nebulized antibiotics and I have tried them in a few patients with no success.   

Analysis: No I don't feel that this will be a great success in treating chronic sinusitis. 

Other Analyses of the Same Source Article:
Naryx antibiotic for chronic sinusitis
April 25, 2007, Author: GLG Expert Contributor
Issue with intranasal antibiotics
April 24, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747